Find qualified African buyers.

Konexium is an autonomous B2B prospecting platform for African markets. You brief Baks, our agent, in one sentence and it researches companies, verifies decision-makers and returns qualified pipeline with evidence on every record.

Yes. Konexium is built for revenue teams and agencies anywhere in the world that sell into African markets. The users are global; the market intelligence is African.

Global databases are broad but thin on African data, which decays fast. Konexium researches from local sources — registries, tenders and news — verifies with evidence, and finds the channels these businesses actually answer on, including the WhatsApp numbers many of them publish and global databases ignore. It also keeps working after the list, with Radar (live market signals) and Market Memory (a learned ICP).

Yes. Many African businesses publish a WhatsApp click-to-chat link on their own website instead of an email address, and Konexium collects it with the page it was found on, so you can see the source. Numbers are never guessed or bought from a checker. Konexium does not send WhatsApp messages — it gives you the link and you start the conversation yourself.

That is the normal case in these markets, and it is why most prospecting tools return an empty list. Konexium reaches the person through their employer's published business address, addressed to them by name and role, and shows any WhatsApp line the company advertises. Addresses are never guessed from a pattern like firstname@company.com.

Coverage spans registries, tenders and local business media across African markets, with the depth, freshness and source mix shown transparently per market on the coverage page.

Konexium is built with NDPR and POPIA in mind: workspace audit trails, suppression lists, consent-aware outreach controls and evidence links, so you can demonstrate accountability.

Yes, in two ways. Every account starts free with welcome credits and no credit card, and the guided onboarding campaign researches up to 10 companies — enough to judge the evidence for yourself. Separately, your first paid subscription begins with a 14-day trial. Failed research is never billed on any plan.